Creating Chemiluminescence Signature Arrays Coupled with Machine Learning for Alzheimer's Disease Serum Diagnosis [0.03%]
基于化学发光标志物阵列结合机器学习的阿尔茨海默病血清诊断方法
Biyue Zhu,Yanbo Li,Shi Kuang et al.
Biyue Zhu et al.
Our strategy could provide new insights into biofluid abnormality and prototype tools for developing liquid biopsy diagnoses for AD and other diseases. Copyright © 2025 Biyue Zhu et al.
A machine-learning approach for pancreatic neoplasia classification based on plasma extracellular vesicles [0.03%]
基于血浆外周膜囊泡的机器学习胰腺肿瘤分类方法
Ioanna Angelioudaki,Angeliki Iosif,Konstadina Kourou et al.
Ioanna Angelioudaki et al.
Efforts to assist early diagnosis focus on liquid biopsy methods, and especially on the detection of Extracellular Vesicles (EVs) secreted from cancer cells in their microenvironment and accumulated in systemic circulation.
Research trends in microRNA profiling as a biomarker for lung adenocarcinoma via liquid biopsy: A bibliometric analysis [0.03%]
基于液体活检的微小核糖核酸谱检测作为肺腺癌生物标志物的研究趋势：文献计量分析
Aprilia I Kartika,Muchamad Dafip,Nastiti Wijayanti et al.
Aprilia I Kartika et al.
A bibliometric analysis of 692 relevant articles identified four primary research clusters: (1) microRNA (19 keywords), which highlights its potential as a biomarker for early detection and diagnosis; (2) lung adenocarcinoma (18 keywords), reflecting advancements in lung cancer research; (3) liquid biopsy
Corrigendum to "Liquid biopsy ¼ Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis" [Oral Oncol. 123 (2021) 105588] [0.03%]
“液体活检＝个体化癌症管理：诊断、监测治疗及复发和转移的筛查”一文的勘误通知
Shrikant Balasaheb Mali,Sachinkumar Dahivelkar
Shrikant Balasaheb Mali
Published Erratum
Oral oncology. 2025 May 10:107355. DOI:10.1016/j.oraloncology.2025.107355 2025
Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy [0.03%]
胰腺癌生物标志物的发现及应用：从早期诊断到个性化治疗
Mohd Haris Jamal,Pratyush Porel,Khadga Raj Aran
Mohd Haris Jamal
Protein-based biomarkers, including glycoproteins and cytokines, alongside liquid biopsy components like circulating tumor DNA (ctDNA), exosomes, and circulating tumor cells (CTCs), facilitate real-time disease monitoring and early detection.
Expanding screening through the use of liquid biopsy for early cancer detection [0.03%]
通过使用液体活检进行早期癌症筛查来扩大筛查范围
Marta Perachino,Carolina Ortiz,Javier Carmona et al.
Marta Perachino et al.
Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoring [0.03%]
循环肿瘤DNA有望成为乳腺癌诊断和治疗监测的生物标志物
Riddhi Ursekar,Rohan Chaubal,Khushboo A Gandhi et al.
Riddhi Ursekar et al.
In conclusion, circulating biomarkers have the potential to revolutionise breast cancer diagnosis, prognosis, and treatment monitoring, but the development of standardised methods for their assessment is essential. ctDNA, in particular, shows great promise as a liquid biopsy tool, but further research
Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world study [0.03%]
基于多生物标志物NGS检测技术的脑脊液中中枢神经系统淋巴瘤来源ctDNA可靠检出性的真实世界研究
Veronika Navrkalova,Andrea Mareckova,Samuel Hricko et al.
Veronika Navrkalova et al.
Less invasive liquid biopsy testing by comprehensive NGS complements standard procedures in the diagnostics and management of CNSL patients, especially when encountering limitations.
Comprehensive review and in silico analysis of the role of noncoding RNAs in retinoblastoma: A step-TowarRNA precision [0.03%]
非编码RNA在视网膜母细胞瘤中的作用的全面回顾与计算机分析：迈向RNA精准治疗的一步
Nadia M Hamdy,Bassant M Barakat,Mona G El-Sisi et al.
Nadia M Hamdy et al.
Emerging data also highlight the intricate crosstalk between piRNAs and other ncRNAs in retinal homeostasis and oncogenesis, with promising future implications for their utility as diagnostic biomarkers in liquid biopsy types.
Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis [0.03%]
液体活检在肝细胞癌中的应用：ctDNA作为诊断和预后的潜在生物标志物
William Yang,Romario Nguyen,Fatema Safri et al.
William Yang et al.
There is an urgent need for less invasive diagnostic strategies, such as liquid biopsy technologies, which allow for repeated sampling and real-time analysis of tumour dynamics.
耗时 0.18346 秒，为您在
48065180
条记录里面共找到 5687 篇文章 [XML]